Finance

Lists
Why is SGMT up 8,48%?
Dive Deeper
SGMT:NASDAQ
Sagimet Biosciences Inc
8,18 $
+8,48%
(+0,64) 1D
15 հոկ, 15:03:32 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SGMT...
Open
7,61 $
High
8,24 $
Low
7,54 $
Mkt. cap
577,66 մլն
Avg. vol.
1,41 մլն
Volume
898,50 հզր
52-wk high
11,45 $
52-wk low
4,50 $
EPS
-1,28 $
Beta
3,46
Shares outstanding
70,34 մլն
No. of employees
16
Open
7,61 $
High
8,24 $
Low
7,54 $
Mkt. cap
577,66 մլն
Avg. vol.
1,41 մլն
Volume
898,50 հզր
52-wk high
11,45 $
52-wk low
4,50 $
EPS
-1,28 $
Beta
3,46
Shares outstanding
70,34 մլն
No. of employees
16
News stories
From web sources and news partners
About Sagimet Biosciences Inc
CEO-
Employees16
Founded2006
HeadquartersSan Mateo, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websitesagimet.com
Analyst ratings
Based on 12 analysts giving stock ratings to SGMT in the past 3 months
Strong buy
Buy
11
Hold
0
Sell
1
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for SGMT in the last 3 months.
Highest
Current 8,18 $
56,00 $ (+584,18%)
Average
28,46 $ (+247,71%)
Lowest
7,00 $ (-14,48%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
29,00 $
+254,3%
10/05/2026
Seamus Fernandez
Guggenheim
Buy
Reiterated
26,00 $
+217,7%
10/01/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
-
-
10/01/2026
Andrea Newkirk
Goldman Sachs
Sell
Maintained
7,00 $
-14,5%
09/30/2026
Jay Olson
Oppenheimer
Buy
Maintained
38,00 $
+364,3%
10/01/2026
Edward Nash
Canaccord Genuity
Buy
Reiterated
56,00 $
+584,2%
10/01/2026
Yanni Souroutzidis
Cantor Fitzgerald
Buy
Maintained
25,10 $
+206,7%
10/01/2026
Yun Zhong
Wedbush
Buy
Maintained
28,00 $
+242,1%
10/01/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
27,00 $
+229,9%
10/01/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
28,00 $
+242,1%
09/30/2026
Debanjana Chatterjee
JonesTrading
Buy
Reiterated
31,00 $
+278,7%
09/27/2026
Eliana Merle
Barclays
Buy
Upgraded
18,00 $
+119,9%
09/09/2026
Ritu Baral
TD Cowen
Buy
Maintained
21,00 $
+156,6%
05/12/2026
Unknown Analyst
Rodman & Renshaw
Buy
Initiated
28,00 $
+242,1%
03/26/2026
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
28,00 $
+242,1%
03/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9,73 մլն
6,73 մլն
7,00 մլն
11,54 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,60 մլն
4,03 մլն
4,72 մլն
4,28 մլն
Operating expense
14,33 մլն
10,76 մլն
11,71 մլն
15,82 մլն
Total operating expenses
14,33 մլն
10,76 մլն
11,71 մլն
15,82 մլն
Operating income
-14,33 մլն
-10,76 մլն
-11,71 մլն
-15,82 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-12,91 մլն
-9,57 մլն
-10,65 մլն
-13,95 մլն
EBT excluding unusual items
-12,91 մլն
-9,57 մլն
-10,65 մլն
-13,95 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12,91 մլն
-9,57 մլն
-10,65 մլն
-13,95 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,40
-0,29
-0,33
-0,26
Interest and investment income
1,43 մլն
1,20 մլն
1,06 մլն
1,86 մլն
Interest expense
-
-
-
-
Net interest expenses
1,43 մլն
1,20 մլն
1,06 մլն
1,86 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps